BIOMAT Database Logo BIOMAT Database Logo

G-protein-coupled receptors for peptide hormones: angiotensin II receptors. 1997

A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Institute for Cardiovascular Research, University of Leeds, U.K.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016297 Mutagenesis, Site-Directed Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion. Mutagenesis, Oligonucleotide-Directed,Mutagenesis, Site-Specific,Oligonucleotide-Directed Mutagenesis,Site-Directed Mutagenesis,Site-Specific Mutagenesis,Mutageneses, Oligonucleotide-Directed,Mutageneses, Site-Directed,Mutageneses, Site-Specific,Mutagenesis, Oligonucleotide Directed,Mutagenesis, Site Directed,Mutagenesis, Site Specific,Oligonucleotide Directed Mutagenesis,Oligonucleotide-Directed Mutageneses,Site Directed Mutagenesis,Site Specific Mutagenesis,Site-Directed Mutageneses,Site-Specific Mutageneses
D044140 Receptor, Angiotensin, Type 1 An angiotensin receptor subtype that is expressed at high levels in a variety of adult tissues including the CARDIOVASCULAR SYSTEM, the KIDNEY, the ENDOCRINE SYSTEM and the NERVOUS SYSTEM. Activation of the type 1 angiotensin receptor causes VASOCONSTRICTION and sodium retention. Angiotensin II Type 1 Receptor,Angiotensin Type 1 Receptor,Angiotensin Type 1a Receptor,Angiotensin Type 1b Receptor,Receptor, Angiotensin, Type 1a,Receptor, Angiotensin, Type 1b,Angiotensin AT1 Receptor,Angiotensin AT1a Receptor,Angiotensin AT1b Receptor,Angiotensin II Type 1a Receptor,Angiotensin II Type 1b Receptor,Receptor, Angiotensin II Type 1,Receptor, Angiotensin II Type 1a,Receptor, Angiotensin II Type 1b,AT1 Receptor, Angiotensin,AT1a Receptor, Angiotensin,AT1b Receptor, Angiotensin,Receptor, Angiotensin AT1,Receptor, Angiotensin AT1a,Receptor, Angiotensin AT1b
D019204 GTP-Binding Proteins Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-. G-Proteins,GTP-Regulatory Proteins,Guanine Nucleotide Regulatory Proteins,G-Protein,GTP-Binding Protein,GTP-Regulatory Protein,Guanine Nucleotide Coupling Protein,G Protein,G Proteins,GTP Binding Protein,GTP Binding Proteins,GTP Regulatory Protein,GTP Regulatory Proteins,Protein, GTP-Binding,Protein, GTP-Regulatory,Proteins, GTP-Binding,Proteins, GTP-Regulatory
D019943 Amino Acid Substitution The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties. Amino Acid Substitutions,Substitution, Amino Acid,Substitutions, Amino Acid

Related Publications

A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
G-protein-coupled receptors for peptide hormones in yeast.
August 1997, Biochemical Society transactions,
A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors.
January 2015, Frontiers in pharmacology,
A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors.
March 2012, Acta pharmacologica Sinica,
A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Peptide interactions with G-protein coupled receptors.
January 2001, Biopolymers,
A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Nonpeptidic ligands for peptide-activated G protein-coupled receptors.
July 2007, Chemical reviews,
A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Human brain receptors, II. G protein-coupled receptors.
March 1994, The American journal of psychiatry,
A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Peptide-Liganded G Protein-Coupled Receptors as Neurotherapeutics.
April 2020, ACS pharmacology & translational science,
A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Peptide G protein-coupled receptors meet at Erice.
September 1998, Trends in pharmacological sciences,
A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Peptide ligand recognition by G protein-coupled receptors.
January 2015, Frontiers in pharmacology,
A J Balmforth, and A J Lee, and F H Shepherd, and P Warburton, and D Donnelly, and S G Ball
Peptide drugs to target G protein-coupled receptors.
September 2010, Trends in pharmacological sciences,
Copied contents to your clipboard!